OR WAIT null SECS
Per the FDA, Kilitch Healthcare India Limited voluntarily recalls 27 eye drop items, including those distributed by CVS, Rite Aid, and Target, due to potential safety issues.
The US Food and Drug Administration (FDA) has announced a nationwide voluntary recall of 27 eye drop products, including those sold at CVS, Rite Aid, and Target, for potential safety reasons, including eye infection risk.1
Announced on November 15, 2023, the eye drop products were voluntarily recalled by manufacturing company Kilitch Healthcare India Limited. The recalled eye drops included all lot numbers with expiration dates ranging from November 2023 to September 2025.
The recall followed a warning released by the FDA on October 27, 2023, recommending manufacturers recall all lots on October 25, 2023, after agency investigators found insanitary conditions and positive bacterial test results from environmental sampling of critical drug production areas.2
The recalled ophthalmic products were nationally distributed to wholesalers, retailers, and through the product distributor, Velocity Pharma LLC.1 The FDA announcement noted the manufacturer has notified the distributor, which will inform wholesalers and retailers via mail of the voluntary recall and arrange for the return of all impacted products.
Kilitch Healthcare India Limited has not received any reports of adverse events related to this recall. However, the FDA has urged consumers, distributors, and retailers that have any product which is being recalled to case the distribution of the product. The agency also warned consumers to cease using the recalled eye drops and return any of the listed ophthalmic products back to the place of purchase.
Ophthalmic products intended for administration into the eye can pose an increased risk of harm to users, as they bypass many of the human body’s natural defenses. Individuals experiencing signs or symptoms of eye infection after drops use were encouraged by the FDA to talk to their healthcare provider or seek immediate medical care, as well as properly discard the product.
Healthcare professionals were urged to report any adverse events or quality problems with any medicine to the FDA’s MedWatch Adverse Event Reporting program.
For the full list of recalled ophthalmic products, view the below list: